• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Special Reports
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Resources
    • About MassDevice
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
    • In-Depth Coverage
    • Latest News
  • Attend DeviceTalks
    • Events
      • DeviceTalks Minnesota – May 4
      • DeviceTalks Boston – May 27–28
      • DeviceTalks West
      • DeviceTalks Tuesdays
    • DeviceTalks Podcast Network
      • DeviceTalks Weekly
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Advertise
  • Subscribe

ACell

Integra LifeSciences to acquire ACell

December 16, 2020 By Danielle Kirsh

Integra LifeSciences (NSDQ:IART) today said it entered into a definitive agreement to acquire ACell. Through the deal, Integra LifeSciences will pay $300 million in cash upfront at closing, subject to customary purchase price adjustments with cash payments of up to an additional $100 million upon certain revenue growth milestones. Columbia, Md.-based ACell currently develops The MatriStem […]

Filed Under: Mergers & Acquisitions Tagged With: ACell, Integra LifeSciences

ACell to pay $15m to settle secret recall charges

June 17, 2019 By Brad Perriello

ACell last week pleaded guilty to a charge that it failed to report a recall of its MicroMatrix wound dressing and settled charges that it violated the False Claims Act, agreeing to pay $15 million to put the matter to rest, the U.S. Justice Dept. said. Columbia, Md.-based ACell also agreed to abide by a […]

Filed Under: Featured, Food & Drug Administration (FDA), Legal News, Wound Care Tagged With: ACell

Aegea Medical picks up former Cardiokinetix, Concentric Medical CEO Sainz | Personnel Moves – May 14, 2018

May 14, 2018 By Fink Densford

Aegea Medical said last week it tapped former Cardiokinetix prez & CEO Maria Sainz as its new president and chief executive officer, effective immediately. Sainz will replace former CEO Don Gurskis, who has held the corner office since 2013. Gurskis will remain on as member of the Redwood City, Calif.-based company’s executive management team. “Maria is […]

Filed Under: Business/Financial News Tagged With: ACell, aegeamedical, Boston Scientific, Cardiac Dimensions Inc., CardioKinetix Inc., cellectbiotechnology, Cerus Corp., Concentric Medical Inc., Conventus Orthopaedics, Cordis Corp., Covidien, GE Healthcare, Guidant Corp., Hillrom, InfraReDx Inc., Nellix Inc., Nipro, Personnel Moves, sciton, Sensus Healthcare LLC, Stryker, Viveve Medical

Ex-Abbott exec Simhambhatla is new Alphaeon CEO | Personnel Moves August 26, 2016

August 26, 2016 By Fink Densford

Ex-Abbott exec Simhambhatla is new Alphaeon CEO Healthcare and social commerce company Alphaeon said last week it tapped former Abbott (NYSE:ABT) senior veep Dr. Murthy Simhambhatla as its new CEO and president, replacing Robert Grant who was recently appointed as vice chair of the company’s board of directors. Dr. Simhambhatla previously operated as a senior partner Strathspey […]

Pages: Page 1 Page 2 Page 3 Page 4

Filed Under: Business/Financial News Tagged With: Abbott, ACell, Alphaeon, Cardiovascular Systems Inc., Clinical Innovations LLC, Guidant Corp., Insulet, Johnson and Johnson, Smith & Nephew, Sunshine Heart Inc.

ACell wins 510(k) for modified MicroMatrix

March 23, 2016 By Fink Densford

ACell said today it won additional FDA 510(k) clearance for its MicroMatrix device allowing the use of the device in conjunction with Cytal wound matrix or Cytal burn matrix devices. The MicroMatrix is a micronized particulate form of ACell’s Urinary Bladder Matrix designed to cover the wound bed in normal or irregular wounds, the Columbia, […]

Filed Under: 510(k), Food & Drug Administration (FDA), Regenerative Medicine, Regulatory/Compliance Tagged With: ACell

Ex-Insulet CFO Roberts lands at Avedro | Personnel Moves

January 23, 2015 By Brad Perriello Leave a Comment

Ex-Insulet CFO Roberts lands at Avedro | Personnel Moves

Filed Under: News Well Tagged With: ACell, AtriCure Inc., Avedro Inc., Avinger, Check-Cap, Covidien, Given Imaging, Hologic, Insulet, Invacare, Nextremity Solutions, OCTANe, OrthoPediatrics Corp., Personnel Moves, Repro-Med Systems Inc., Zimmer Biomet

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >
MDO ad
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2026 · Arrowfly LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy